HealthQuill Drugs
The toxicity rate related to benzodiazepine, a drug used to treat insomnia and anxiety and doubles up as an opioid, rose sharply in young adults and youth in Canada’s Ontario province that borders the US.
Drugs Health Pharma

Rising toxicity in Benzos snorted by Ontario’s young adults raises alarm in Canada

HQ Team June 20, 2023: The toxicity rate related to benzodiazepine, a drug used to treat insomnia and anxiety and doubles up as.

Read More
Access to pain relief medication, morphine, is ‘one of the most heinous, hidden inequities in global health’ with the richest 10% of countries possessing 90% of distributed morphine-equivalent opioids, according to a WHO report.
Drugs Health Pharma

Denial of morphine most ‘heinous’ inequity in global health: WHO

HQ Team June 17, 2023: Access to pain relief medication, morphine, is ‘one of the most heinous, hidden inequities in global health’ with.

Read More
The UN has adopted a new manifesto, the Rabat Declaration, to strengthen the global commitment to improve the health of refugees and migrants.
Climate Drugs Health Pharma

UN adopts Rabat Declaration on refugee, migrant health

HQ Team June 17, 2023: The UN has adopted a new manifesto, the Rabat Declaration, to strengthen the global commitment to improve the health.

Read More
The number of sequences to detect the presence of the Covid-19 viral genome, being shared with WHO, has dropped by more than 90%, and the number of countries sharing them has fallen by a third.
Drugs Health Medical Pharma

FDA committee recommends updating COVID booster shots to include new variants

"We need a periodic update. Second, it’s time to move from the current bivalent to a monovalent vaccines."

Read More
A new magnetic resonance imaging (MRI) technique has revealed that the Covid-19 virus alters white matter in the brain.
Drugs Health Pharma

MRI technique shows Covid-19 virus alters white matter in brain

HQ Team June 15, 2023: A new magnetic resonance imaging (MRI) technique has revealed that the Covid-19 virus alters white matter in the.

Read More
Pfizer Inc. announced a shortage of several doses of penicillin to treat strep throat and other infections in the US, as demand for the drug increased due to a rise in syphilis infection rates.
Drugs Health Pharma

Pfizer warns of penicillin shortage as syphilis rates rise in United States

HQ Team June 14, 2023: Pfizer Inc. announced a shortage of several doses of penicillin to treat strep throat and other infections in.

Read More
Long-Covid-19 patients have fatigue similar to cancer-related anemia, severe kidney disease, and Parkinson’s disease, a study by the  University College of London found.
Drugs Health Pharma

Fatigue in long Covid patients same as in stage IV lung cancer

HQ Team June 14, 2023: Long-Covid-19 patients have fatigue similar to cancer-related anemia, severe kidney disease, and Parkinson’s disease, a study by the .

Read More
Valneva SE, a French vaccine maker, announced that its last-stage trials for its single-shot chikungunya registered a 98.9% vaccination success rate.
Drugs Medical Pharma

France’s Valneva says trial vaccine for chikungunya post 98.9% rate

HQ Team June 13, 2023: Valneva SE, a French vaccine maker, announced that its last-stage trials for its single-shot chikungunya registered a 98.9%.

Read More
Denmark’s Novo Nordisk will invest 15.9 billion kroner ($2.30 billion) to expand its Hillerød production facility in the country to make new active pharmaceutical ingredients.
Drugs Health Pharma

Novo Nordisk to invest $2.3 billion to expand Danish facility 

HQ Team June 13, 2023: Denmark’s Novo Nordisk will invest 15.9 billion kroner ($2.30 billion) to expand its Hillerød production facility in the.

Read More
Swiss drugmaker, Novartis signed a $3.5 billion deal with Chinook Therapeutics to boost the US-based company’s last-stage experimental trials of two drugs to treat chronic kidney diseases.
Drugs Health Pharma

Novartis to acquire Chinook Therapeutics in a $3.5 billion deal

HQ Team June 13, 2023: Swiss drugmaker, Novartis signed a $3.5 billion deal with Chinook Therapeutics to boost the US-based company’s last-stage experimental.

Read More